von Bergwelt-Baildon

Apr 23, 2023 | paperity.org | von Bergwelt-Baildon

Journal of Cancer Research and Clinical Oncology, Apr 2023 This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007/s00432-023-04741-y.pdf Weiss, L., Heinrich, K., Zhang, D., Dorman, K., Rühlmann, K., Hasselmann, K., Klauschen, F., Kumbrink, J., Jung, A., Rudelius, M., Mock, A., Ormanns, Steffen, Kunz, W.

Apr 21, 2023 | paperity.org | von Bergwelt-Baildon

Leukemia, Apr 2023 This is a preview of a remote PDF: https://www.nature.com/articles/s41375-023-01884-2.pdf Rausch, Christian, Rothenberg-Thurley, Maja, Dufour, Annika, Schneider, Stephanie, Gittinger, Hanna, Sauerland, Cristina, Görlich, Dennis, Krug, Utz, Berdel, Wolfgang E., Woermann, Bernhard J., Hiddemann, Wolfgang, Braess, Jan, von Bergwelt-Baildon, Michael, Spiekermann, Karsten, Herold, Tobias, Metzeler, Klaus H..

Apr 3, 2023 | ashpublications.org | Friedrich-Alexander-Universität Erlangen-Nürnberg |Universitat Autònoma |von Bergwelt-Baildon

TO THE EDITOR: Despite the curative potential of chimeric antigen receptor (CAR) T cells, a significant number of patients fail to respond, underlining the need for precise patient monitoring.1-3 Currently, assessing responses in real-world settings is mainly based on radiography at 1 and 3 months after CAR T-cell infusion.4-6 However, because disease progression is rapid in heavily pretreated patients, earlier detection of treatment failure would be favorable, so that salvage treatment can...